Doxazosin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
59651-892 -
Package NDC
59651-892-01 -
Package NDC
59651-892-99 -
Application number
ANDA075509 -
SPL ID
a3c03b74-51e7-4df3-a5db-78e4453e52aa -
SPL set ID
93f2d724-5a54-4721-b04a-e46bc764607b -
UNII
86P6PQK0MU -
RxCUI
197625 -
RxCUI
197626 -
RxCUI
197627 -
RxCUI
197628
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- doxazosin mesylate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Doxazosin",
"splId": "a3c03b74-51e7-4df3-a5db-78e4453e52aa",
"labels": [
{
"setId": "93f2d724-5a54-4721-b04a-e46bc764607b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93f2d724-5a54-4721-b04a-e46bc764607b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=93f2d724-5a54-4721-b04a-e46bc764607b"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (59651-892-01)",
"package_ndc": "59651-892-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20240301"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (59651-892-99)",
"package_ndc": "59651-892-99",
"identifierStatus": "well-formed",
"marketing_start_date": "20240301"
}
],
"productId": "59651-892_a3c03b74-51e7-4df3-a5db-78e4453e52aa",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "59651-892",
"deaSchedule": null,
"genericName": "doxazosin mesylate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DOXAZOSIN MESYLATE",
"strength": "1 mg/1"
}
],
"applicationNumber": "ANDA075509",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240301",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"86P6PQK0MU"
],
"rxcui": [
"197625",
"197626",
"197627",
"197628"
],
"spl_set_id": [
"93f2d724-5a54-4721-b04a-e46bc764607b"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:59651-892_a3c03b74-51e7-4df3-a5db-78e4453e52aa"